These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37993530)

  • 1. Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing.
    Kia P; Katagirya E; Kakembo FE; Adera DA; Nsubuga ML; Yiga F; Aloyo SM; Aujat BR; Anguyo DF; Katabazi FA; Kigozi E; Joloba ML; Kateete DP
    Sci Rep; 2023 Nov; 13(1):20507. PubMed ID: 37993530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-genome sequencing of SARS-CoV-2 reveals diverse mutations in circulating Alpha and Delta variants during the first, second, and third waves of COVID-19 in South Kivu, east of the Democratic Republic of the Congo.
    Ntagereka PB; Oyola SO; Baenyi SP; Rono GK; Birindwa AB; Shukuru DW; Baharanyi TC; Kashosi TM; Buhendwa JC; Bisimwa PB; Kusinza AB; Basengere RA; Mukwege D
    Int J Infect Dis; 2022 Sep; 122():136-143. PubMed ID: 35598737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Genomic Variants of SARS-CoV-2 Using Nanopore Sequencing.
    Capraru ID; Romanescu M; Anghel FM; Oancea C; Marian C; Sirbu IO; Chis AR; Ciordas PD
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557043
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.
    Chan WS; Au CH; Lam HY; Wang CLN; Ho DN; Lam YM; Chu DKW; Poon LLM; Chan TL; Zee JS; Ma ESK; Tang BSF
    Virol J; 2020 Nov; 17(1):183. PubMed ID: 33225958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of SARS-CoV-2 testing and genomic sequencing into influenza sentinel surveillance in Uganda, January to December 2022.
    Kayiwa JT; Nassuna C; Mulei S; Kiggundu G; Nakaseegu J; Nabbuto M; Amwine E; Nakamoga B; Nankinga S; Atuhaire P; Nabiryo P; Alunzi P; Mbaziira T; Isabirye P; Ayuro N; Owor N; Kiconco J; Bakamutumaho B; Middlebrook EA; Kaleebu P; Lutwama JJ; Bartlow AW
    Microbiol Spectr; 2023 Dec; 11(6):e0132823. PubMed ID: 37811997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India.
    Gupta N; Kaur H; Yadav PD; Mukhopadhyay L; Sahay RR; Kumar A; Nyayanit DA; Shete AM; Patil S; Majumdar T; Rana S; Gupta S; Narayan J; Vijay N; Barde P; Nataraj G; B AK; Kumari MP; Biswas D; Iravane J; Raut S; Dutta S; Devi S; Barua P; Gupta P; Borkakoty B; Kalita D; Dhingra K; Fomda B; Joshi Y; Goyal K; John R; Munivenkatappa A; Dhodapkar R; Pandit P; Devi S; Dudhmal M; Kinariwala D; Khandelwal N; Tiwari YK; Khatri PK; Gupta A; Khatri H; Malhotra B; Nagasundaram M; Dar L; Sheikh N; Shastri J; Aggarwal N; Abraham P
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022.
    Nduwimana C; Nzoyikorera N; Ndihokubwayo A; Ihorimbere T; Nibogora C; Ndoreraho A; Hajayandi O; Bizimana JC; Diawara I; Niyonizigiye D; Nyandwi J
    BMC Genomics; 2023 Jun; 24(1):312. PubMed ID: 37301830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021: Towards refinement of COVID-19 disease vaccines, diagnostics, and therapeutics.
    Odongo S; Okella H; Ndekezi C; Okee M; Namayanja M; Mujuni B; Sterckx YGJ; Kizito D; Radwanska M; Magez S; Ikwap K; Mwiine FN; Lutwama JJ; Ibingira C
    PLoS One; 2022; 17(12):e0279428. PubMed ID: 36548384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Surveillance of Five SARS-CoV-2 Clinical Samples in Henan Province Using Nanopore Sequencing.
    Wang Y; Chen D; Zhu C; Zhao Z; Gao S; Gou J; Guo Y; Kong X
    Front Immunol; 2022; 13():814806. PubMed ID: 35444655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries.
    Ahmad SU; Hafeez Kiani B; Abrar M; Jan Z; Zafar I; Ali Y; Alanazi AM; Malik A; Rather MA; Ahmad A; Khan AA
    J Infect Public Health; 2022 Aug; 15(8):878-891. PubMed ID: 35839568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Analysis of SARS-CoV-2 Lineages in Armenia.
    Avetyan D; Hakobyan S; Nikoghosyan M; Ghukasyan L; Khachatryan G; Sirunyan T; Muradyan N; Zakharyan R; Chavushyan A; Hayrapetyan V; Hovhannisyan A; Mohamed Bakhash SA; Jerome KR; Roychoudhury P; Greninger AL; Niazyan L; Davidyants M; Melik-Andreasyan G; Sargsyan S; Nersisyan L; Arakelyan A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.
    Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G;
    Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wastewater Genomic Surveillance Captures Early Detection of Omicron in Utah.
    Gupta P; Liao S; Ezekiel M; Novak N; Rossi A; LaCross N; Oakeson K; Rohrwasser A
    Microbiol Spectr; 2023 Jun; 11(3):e0039123. PubMed ID: 37154725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portable RT-PCR and MinION Nanopore Sequencing as a Proof-of-Concept SARS-CoV-2 Biosurveillance in Wastewater.
    Pavlyuk OM; Engler J; Strapple C; Stamps BW; Dietrich MT
    MSMR; 2023 May; 30(5):9-14. PubMed ID: 37535262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Clinical Characteristics and Virus Strains Variation of Patients Infected With SARS-CoV-2 in Jiangsu Province-A Retrospective Study.
    Wang S; Zou X; Li Z; Fu J; Fan H; Yu H; Deng F; Huang H; Peng J; Zhao K; Cui L; Zhu L; Bao C
    Front Public Health; 2021; 9():791600. PubMed ID: 35004593
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid identification of SARS-CoV-2 strains via isothermal enzymatic recombinase amplification and nanopore sequencing.
    Tran DH; Do HDK; Tran HT; Pham TNM; Nguyen HD; Linh HT; Cuong HQ; Vu MT; Phung HTT
    Arch Virol; 2024 Apr; 169(5):87. PubMed ID: 38565796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-COV-2 genomic monitoring in the state of São Paulo unveils two emerging AY.43 sublineages.
    Lima ARJ; Ribeiro G; Viala VL; de Lima LPO; Martins AJ; Barros CRDS; Marqueze EC; Bernardino JST; Moretti DB; Rodrigues ES; Santos EV; Brassaloti RA; Cassano RLRC; Mariani PDSC; Clemente LG; Assato PA; Costa FADSD; Poleti MD; Lesbon JCC; Mattos EC; Banho CA; Sacchetto L; Moraes MM; Palmieri M; Martininghi M; Caldeira LAV; Silva FEVD; Grotto RMT; Souza-Neto JA; Giovanetti M; Junior Alcantara LC; Nogueira ML; Fukumasu H; Coutinho LL; Kashima S; Neto RM; Covas DT; Slavov SN; Sampaio SC; Elias MC
    J Med Virol; 2022 Jul; 94(7):3394-3398. PubMed ID: 35229308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking SARS-COV-2 variants using Nanopore sequencing in Ukraine in 2021.
    Yakovleva A; Kovalenko G; Redlinger M; Liulchuk MG; Bortz E; Zadorozhna VI; Scherbinska AM; Wertheim JO; Goodfellow I; Meredith L; Vasylyeva TI
    Sci Rep; 2022 Sep; 12(1):15749. PubMed ID: 36131001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing.
    Buenestado-Serrano S; Herranz M; Otero-Sobrino Á; Molero-Salinas A; Rodríguez-Grande C; Sanz-Pérez A; Durán Galván MJ; Catalán P; Alonso R; Muñoz P; Pérez-Lago L; García de Viedma D;
    Int J Med Microbiol; 2024 Mar; 314():151599. PubMed ID: 38290400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 genomic surveillance in Malaysia: displacement of B.1.617.2 with AY lineages as the dominant Delta variants and the introduction of Omicron during the fourth epidemic wave.
    Azami NAM; Perera D; Thayan R; AbuBakar S; Sam IC; Salleh MZ; Isa MNM; Ab Mutalib NS; Aik WK; Suppiah J; Tan KK; Chan YF; Teh LK; Azzam G; Rasheed ZBM; Chan JCJ; Kamel KA; Tan JY; Khalilur Rahman O; Lim WF; Johari NA; Ishak M; Yunos RIM; Anasir MI; Wong JE; Fu JYL; Noorizhab MNF; Sapian IS; Mokhtar MFM; Md Shahri NAA; Ghafar K; Yusuf SNHM; Noor YM; Jamal R;
    Int J Infect Dis; 2022 Dec; 125():216-226. PubMed ID: 36336246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.